CLIA lab

CLIA 15D2258457: Affect Therapeutics Inc

Indianapolis, IN. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 15D2258457 belongs to Affect Therapeutics Inc in Indianapolis, IN.

Certificate of Waiver, effective April 21, 2026, expires April 20, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
April 21, 2026
Certificate expiration
April 20, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
April 21, 2022
Facility type
Comprehensive outpatient rehab facility
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
15D2258457
Lab name
Affect Therapeutics Inc
Address
863 Massachusetts Ave, Office 220, Indianapolis, IN 46206
Phone
(845) 769-8758

Annual test volume the lab reported

Waived tests
25,000

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Indianapolis, IN

Related

Questions

What is the CLIA number for Affect Therapeutics Inc in Indianapolis?

15D2258457, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Affect Therapeutics Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 15D2258457 expire?

The CMS file lists April 20, 2028 as the certificate expiration date; the certificate took effect April 21, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.